COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.

ABSTRACT:

Background

Individuals with cancer, particularly those who are receiving systemic anticancer treatments, have been postulated to be at increased risk of mortality from COVID-19. This conjecture has considerable effect on the treatment of patients with cancer and data from large, multicentre studies to support this assumption are scarce because of the contingencies of the pandemic. We aimed to describe the clinical and demographic characteristics and COVID-19 outcomes in patients with cancer.

Methods

In this prospective observational study, all patients with active cancer and presenting to our network of cancer centres were eligible for enrolment into the UK Coronavirus Cancer Monitoring Project (UKCCMP). The UKCCMP is the first COVID-19 clinical registry that enables near re

SUBMITTER: Lee LY 

PROVIDER: S-EPMC7255715 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature